ASSOBRAFIR vs ExPreS
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ASSOBRAFIR
This app provides members of the Brazilian Association of Cardiorespiratory Physiotherapy and Intensive Care Physiotherapy with news, push notifications, and association status updates. It offers a fully online and digital experience for members.
- News updates
- Push notifications
- Association status check
- Digital member benefits
- Online platform
Read full descriptionHide full description
O App da ASSOBRAFIR é mais um benefício para os associados. Acompanhe nossas notícias, notificações via push, confira o status da sua associação e muito mais! A Associação Brasileira de Fisioterapia Cardiorrespiratória e Fisioterapia em Terapia Intensiva agora em versão totalmente on-line e 100% digital.
ExPreS
Read full descriptionHide full description
ExPreS (Extubation Predictive Score) is a predictive score of success in the extubation of mechanically ventilated patients, published in 2021 in the PLOS ONE journal by the team of Nexo Healthcare Intelligence. And now was transformed into a mobile app to make its use simple and easy. Get decision-making support in the palm of your hand. During its scientific validation, ExPreS reduced the extubation failure rate from 8.2% to 2.4%, proving to be easy to use at the bedside and an excellent decision-support tool for weaning and extubation. ExPreS is the first score to evaluate the patient in a multisystemic way and includes peripheral muscular strength as a predictive factor for success in extubation.
Screenshots
Verdict
The clearest difference is iOS requirement: ExPreS at 12.0 against ASSOBRAFIR's 15.1. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ASSOBRAFIR ships an update every 3 months, ExPreS every 4 months. The most recent releases landed on October 5, 2026 and October 10, 2026 respectively.
| Parameter | ASSOBRAFIR | ExPreS |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 0.0% of reviews | — |
| Update frequency | Every 3 months — better | Every 4 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.1 | 12.0 — better |
| Further details — not scored | ||
| Size | 68 MB | 29 MB |
| Age rating | 4+ | 4+ |
| Developer | Itarget Tecnologia | Nexo Healthcare Intelligence |
In-app purchases
ASSOBRAFIR
No in-app purchases
ExPreS
No in-app purchases
